Microcures Inc.
NY
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1300 Morris Park Ave, Bronx, NY 10461, USA
- Website
- microcures.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Albert Einstein College Of Medicine | R01DK136889 | $61,600 | |
| Albert Einstein College Of Medicine | R01DK136889 | $61,600 | |
| Albert Einstein College Of Medicine | R01DK136889 | $59,136 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Human Cell Co | Naperville, IL | — |
| Ortholevo, Inc. | Lynnfield, MA | 325412 Pharmaceutical Preparation Manufacturing |
| New York R&D Center For Translational Medicine And Therapeutics, Inc. | New Rochelle, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Fibroplate Inc. | Las Vegas, NV | 325414 Biological Product (except Diagnostic) Manufacturing |
| Adepthera LLC | Palo Alto, CA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Microcures Inc. is a corporate entity registered in SAM.gov since November 2014, operating as a for-profit organization focused on developing innovative therapeutic solutions in the biomedical research sector. While specific details about the company's full background are not provided, the federal grant awards suggest the company specializes in developing advanced nanoparticle-based treatments targeting specific molecular mechanisms for tissue repair and regeneration. The company is not currently registered to receive federal contract vehicles but has been actively engaged in federal grant awards, primarily in the medical research domain.
Microcures Inc. has received significant federal grant awards from prominent medical research agencies, specifically the National Institute of Neurological Disorders and Stroke and the National Eye Institute. The company's primary research focus involves developing nanoparticle-encapsulated siRNA treatments targeting the Fidgetin-like 2 (FL2) protein to promote tissue healing and functional recovery. Their recent grant awards include a $41NS137941 project targeting spinal cord injury regeneration and an R42EY034791 grant for corneal repair therapeutics. Additionally, the company has engaged in sub-grant collaborations with prestigious research institutions like Albert Einstein College of Medicine and The Henry M. Jackson Foundation for the Advancement of Military Medicine. These grants collectively demonstrate Microcures' commitment to developing innovative therapeutic interventions for complex medical conditions, with a particular emphasis on neural and tissue regeneration using advanced molecular targeting techniques.
Quick answers
Is Microcures Inc. registered in SAM.gov?
Yes. Microcures Inc.'s SAM.gov registration is active through January 22, 2027.
What is Microcures Inc.'s CAGE code?
Microcures Inc.'s CAGE code is 79J36, and its Unique Entity ID (UEI) is KTD9TQGMNMR1.
What is Microcures Inc.'s most recent federal award?
Microcures Inc.'s most recent federal grant award is Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory… (R41NS137941), from National Institute of Neurological Disorders and Stroke (NIH), on May 15, 2025.
On GovTribe
See Microcures Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors